脳卒中管理の世界市場レポート 2025年

脳卒中管理市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.7％で581億5,000万米ドルに成長します。予測期間の成長は、神経保護療法の出現、脳卒中診断における人工知能、個別化医療アプローチ、急性期治療へのアクセス拡大、世界の脳卒中治療の標準化などに起因すると考えられます。予測期間における主な動向には、医療画像技術の進歩、遠隔医療と遠隔モニタリング、予防医療と危険因子管理の重視、神経保護療法と薬剤の革新、連携と学際的アプローチが含まれます。

慢性疾患の罹患率の上昇が、今後の脳卒中管理市場の成長を牽引すると予想されます。慢性疾患とは、1年以上持続して日常生活に支障をきたし、しばしば継続的な医療を必要とする状態を指します。脳卒中管理は、予防医療、教育、患者のエンパワーメントに注力するとともに、一次医療と二次医療を組み合わせた統合ケア提供モデルを開発することで、がんや心血管疾患など様々な慢性疾患の患者をサポートする上で重要な役割を果たしています。例えば、2022年8月、米国を拠点とする非営利の医学団体である米国心臓病学会の報告書は、米国における4大心血管系危険因子のすべてが2025年から2060年にかけて増加すると予測しました。糖尿病が最も著しく増加し、39.3％増の5,500万人、次いで脂質異常症（27.6％増の1億2,600万人）、高血圧（25.1％増の1億6,200万人）、肥満（18.3％増の1億2,600万人）が続くと予想されています。さらに、脳卒中（33.8％→1,500万人）、心不全（33.4％→1,300万人）、虚血性心疾患（30.7％→2,900万人）、心臓発作（16.9％→1,600万人）など、心血管疾患の大幅な増加が予想されます。したがって、慢性疾患の罹患率の増加が脳卒中管理市場の成長を牽引しています。

老年人口の増加が今後の脳卒中管理市場の成長を牽引すると予想されます。老人人口には65歳以上の高齢者が含まれ、加齢に伴うさまざまな生物学的、社会学的、心理学的変化を特徴とする人口層です。例えば、2024年1月、統計を収集・提供することを目的とした米国の非営利団体である人口問題研究所は、65歳以上の米国人の数が2022年の5,800万人から2050年には8,200万人へと47%増加すると予測しています。したがって、老人人口の増加は脳卒中管理市場の成長を促進する重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界脳卒中管理PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の脳卒中管理市場：成長率分析
• 世界の脳卒中管理市場の実績：規模と成長, 2019-2024
• 世界の脳卒中管理市場の予測：規模と成長, 2024-2029, 2034F
• 世界脳卒中管理総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の脳卒中管理市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断
• 薬物療法製品
• 介入脳卒中管理システム
• 世界の脳卒中管理市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 虚血性脳卒中
• 出血性脳卒中
• 世界の脳卒中管理市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 外来手術センター
• 診断センター
• 小売薬局
• オンライン薬局
• その他のエンドユーザー
• 世界の脳卒中管理市場、診断のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• イメージングシステム
• 診断ソフトウェア
• 血液検査
• 世界の脳卒中管理市場、薬物療法製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗凝固剤
• 抗血小板薬
• 血栓溶解剤
• 降圧薬
• 世界の脳卒中管理市場、介入システムのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血栓除去装置
• ステント回収装置
• 塞栓保護デバイス
• 頸動脈ステントシステム

第7章 地域別・国別分析

• 世界の脳卒中管理市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の脳卒中管理市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 脳卒中管理市場：競合情勢
• 脳卒中管理市場：企業プロファイル
  • GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • B Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bristol Myers Squibb Co.
• Cardinal Health Inc.
• Siemens Healthineers
• Merck And Co. Inc.
• Asahi Intech Co. Ltd.
• Johnson & Johnson
• Penumbra Inc.
• Teleflex Inc.
• Stryker Corporation
• Biogen Inc.
• Bayer AG
• Philips Healthcare
• AstraZeneca Plc.
• F. Hoffmann-la Roche
• Novartis AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 脳卒中管理市場2029：新たな機会を提供する国
• 脳卒中管理市場2029：新たな機会を提供するセグメント
• 脳卒中管理市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Stroke management involves the treatment administered when a blood vessel in the brain bursts or when something obstructs the blood flow to a specific area of the brain, resulting in the brain aging or sustaining damage.

The primary product categories within stroke management include diagnostics, drug therapy products, and interventional stroke management systems. Diagnostics pertain to procedures aimed at identifying a disease, ailment, or injury based on its symptoms and indications. These diagnostic tools find applications in various scenarios such as ischemic stroke and hemorrhagic stroke. Additionally, they cater to diverse end-users, including hospitals, clinics, ambulatory surgery centers, diagnostic centers, retail pharmacies, online pharmacies, and others.

The stroke management market research report is one of a series of new reports from The Business Research Company that provides stroke management market statistics, including stroke management industry global market size, regional shares, competitors with a stroke management market share, detailed stroke management market segments, market trends and opportunities, and any further data you may need to thrive in the stroke management industry. This stroke management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The stroke management market size has grown strongly in recent years. It will grow from$40.24 billion in 2024 to $43.28 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to thrombolytic therapies, stroke prevention initiatives, rehabilitation techniques, telemedicine in stroke care, collaborative stroke networks

The stroke management market size is expected to see strong growth in the next few years. It will grow to $58.15 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to emergence of neuroprotective therapies, artificial intelligence in stroke diagnosis, personalized medicine approaches, expanding access to acute care, global stroke care standardization. Major trends in the forecast period include advancements in medical imaging technology, telemedicine and remote monitoring, focus on preventive care and risk factor management, neuroprotective therapies and drug innovations, collaboration and multidisciplinary approaches.

The rising incidence of chronic diseases is expected to drive the growth of the stroke management market in the future. Chronic diseases are defined as conditions that persist for a year or longer and hinder daily activities, often requiring ongoing medical care. Stroke management plays a crucial role in supporting patients with various chronic conditions, such as cancer and cardiovascular diseases, by focusing on preventive care, education, and empowering patients, as well as developing integrated care delivery models that combine primary and secondary care. For instance, in August 2022, a report from the American College of Cardiology, a U.S.-based non-profit medical association, projected that all four major cardiovascular risk factors in the United States will increase from 2025 to 2060. Diabetes is expected to see the most significant rise, with a 39.3% increase to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Additionally, substantial increases in cardiovascular disease rates are anticipated, including stroke (33.8% to 15 million) and heart failure (33.4% to 13 million), with ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million) following closely. Therefore, the increasing incidence of chronic diseases is driving the growth of the stroke management market.

The increasing geriatric population is expected to drive the growth of the stroke management market in the future. The geriatric population includes individuals aged 65 and older, a demographic characterized by various biological, sociological, and psychological changes associated with aging. For example, in January 2024, the Population Reference Bureau, a U.S.-based nonprofit organization focused on collecting and providing statistics, projected that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Therefore, the growing geriatric population is a significant factor propelling the growth of the stroke management market.

Major companies in the stroke management market are increasingly focused on developing neurovascular technology to improve the diagnosis, treatment, and recovery processes for stroke patients. Neurovascular technology includes medical devices, techniques, and procedures aimed at diagnosing, treating, and managing conditions related to the brain's blood vessels and the nervous system. For example, in October 2022, Medtronic, an Ireland-based company specializing in medical technologies, launched a new platform designed to accelerate innovation in stroke care. This platform combines advanced imaging and data analytics to enhance decision-making, streamline workflows, and improve patient outcomes during stroke interventions. The new technology aims to equip clinicians with better tools for rapid diagnosis and treatment, facilitating timely interventions that can significantly mitigate the effects of strokes on patients.

Major players in the stroke management market are directing their efforts towards introducing innovative products, such as a portfolio of Ischemic stroke solutions, to gain a competitive advantage. An example is MicroVention Inc., a US-based neuroendovascular medical device company, which launched the Eric retrieval device for treating ischemic stroke in the US in June 2023. Eric, a self-expanding laser-cut clot retriever, features multiple retrieval cages on a pusher wire delivery system. MicroVention emphasizes the device's atraumatic design, following natural vessel guidelines to provide mild outward radial force, minimal vessel wall contact, and remarkable flexibility.

In December 2022, Johnson & Johnson, a US-based pharmaceutical industry company, acquired Abiomed, Inc. This strategic move aimed to expand Johnson & Johnson's MedTech business growth, delivering cutting-edge medical innovations globally. Abiomed Inc., a US-based medical device technology company, specializes in developing and manufacturing stroke management devices, including heart pumps.

Major companies operating in the stroke management market include GE HealthCare Technologies Inc., Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, B Braun Melsungen AG, Bristol Myers Squibb Co., Cardinal Health Inc., Siemens Healthineers, Merck And Co. Inc., Asahi Intech Co. Ltd., Johnson & Johnson, Penumbra Inc., Teleflex Inc., Stryker Corporation, Biogen Inc., Bayer AG, Philips Healthcare, AstraZeneca Plc., F. Hoffmann-la Roche, Novartis AG, Takeda Pharmaceutical Company Ltd., Sanofi SA, Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, Pfizer Inc.

North America was the largest region in the stroke management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global stroke management market report during the forecast period. The regions covered in the stroke management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the stroke management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The stroke management market includes revenues earned by entities by providing hyperacute care, acute care, rehabilitation, control of bleeding, and basic life support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stroke Management Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stroke management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stroke management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The stroke management market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Diagnostics; Drug Therapy Products; Interventional Stroke Management Systems
• 2) By Application: Ischemic Stroke; Hemorrhagic Stroke
• 3) By End-User: Hospitals; Clinics; Ambulatory Surgery Centers; Diagnostic Centers; Retail Pharmacies; Online Pharmacies; Other End Users
• Subsegments:
• 1) By Diagnostics: Imaging Systems; Diagnostic Software; Blood Tests
• 2) By Drug Therapy Products: Anticoagulants; Antiplatelet Drugs; Thrombolytic Agents; Antihypertensive Drugs
• 3) By Interventional Stroke Management Systems: Clot Retrieval Devices; Stent Retrievers; Embolic Protection Devices; Carotid Artery Stenting Systems
• Companies Mentioned: GE HealthCare Technologies Inc.; Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; B Braun Melsungen AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Stroke Management Market Characteristics

3. Stroke Management Market Trends And Strategies

4. Stroke Management Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Stroke Management Growth Analysis And Strategic Analysis Framework

• 5.1. Global Stroke Management PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Stroke Management Market Growth Rate Analysis
• 5.4. Global Stroke Management Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Stroke Management Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Stroke Management Total Addressable Market (TAM)

6. Stroke Management Market Segmentation

• 6.1. Global Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostics
• Drug Therapy Products
• Interventional Stroke Management Systems
• 6.2. Global Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ischemic Stroke
• Hemorrhagic Stroke
• 6.3. Global Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Ambulatory Surgery Centers
• Diagnostic Centers
• Retail Pharmacies
• Online Pharmacies
• Other End Users
• 6.4. Global Stroke Management Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Systems
• Diagnostic Software
• Blood Tests
• 6.5. Global Stroke Management Market, Sub-Segmentation Of Drug Therapy Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anticoagulants
• Antiplatelet Drugs
• Thrombolytic Agents
• Antihypertensive Drugs
• 6.6. Global Stroke Management Market, Sub-Segmentation Of Interventional Stroke Management Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clot Retrieval Devices
• Stent Retrievers
• Embolic Protection Devices
• Carotid Artery Stenting Systems

7. Stroke Management Market Regional And Country Analysis

• 7.1. Global Stroke Management Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Stroke Management Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Stroke Management Market

• 8.1. Asia-Pacific Stroke Management Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Stroke Management Market

• 9.1. China Stroke Management Market Overview
• 9.2. China Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Stroke Management Market

• 10.1. India Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Stroke Management Market

• 11.1. Japan Stroke Management Market Overview
• 11.2. Japan Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Stroke Management Market

• 12.1. Australia Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Stroke Management Market

• 13.1. Indonesia Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Stroke Management Market

• 14.1. South Korea Stroke Management Market Overview
• 14.2. South Korea Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Stroke Management Market

• 15.1. Western Europe Stroke Management Market Overview
• 15.2. Western Europe Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Stroke Management Market

• 16.1. UK Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Stroke Management Market

• 17.1. Germany Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Stroke Management Market

• 18.1. France Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Stroke Management Market

• 19.1. Italy Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Stroke Management Market

• 20.1. Spain Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Stroke Management Market

• 21.1. Eastern Europe Stroke Management Market Overview
• 21.2. Eastern Europe Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Stroke Management Market

• 22.1. Russia Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Stroke Management Market

• 23.1. North America Stroke Management Market Overview
• 23.2. North America Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Stroke Management Market

• 24.1. USA Stroke Management Market Overview
• 24.2. USA Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Stroke Management Market

• 25.1. Canada Stroke Management Market Overview
• 25.2. Canada Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Stroke Management Market

• 26.1. South America Stroke Management Market Overview
• 26.2. South America Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Stroke Management Market

• 27.1. Brazil Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Stroke Management Market

• 28.1. Middle East Stroke Management Market Overview
• 28.2. Middle East Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Stroke Management Market

• 29.1. Africa Stroke Management Market Overview
• 29.2. Africa Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Stroke Management Market Competitive Landscape And Company Profiles

• 30.1. Stroke Management Market Competitive Landscape
• 30.2. Stroke Management Market Company Profiles
  • 30.2.1. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. B Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

31. Stroke Management Market Other Major And Innovative Companies

• 31.1. Bristol Myers Squibb Co.
• 31.2. Cardinal Health Inc.
• 31.3. Siemens Healthineers
• 31.4. Merck And Co. Inc.
• 31.5. Asahi Intech Co. Ltd.
• 31.6. Johnson & Johnson
• 31.7. Penumbra Inc.
• 31.8. Teleflex Inc.
• 31.9. Stryker Corporation
• 31.10. Biogen Inc.
• 31.11. Bayer AG
• 31.12. Philips Healthcare
• 31.13. AstraZeneca Plc.
• 31.14. F. Hoffmann-la Roche
• 31.15. Novartis AG

32. Global Stroke Management Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Stroke Management Market

34. Recent Developments In The Stroke Management Market

35. Stroke Management Market High Potential Countries, Segments and Strategies

• 35.1 Stroke Management Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Stroke Management Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Stroke Management Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer